Brochure
Fully-connected continuous manufacturingTM (FCCMTM) represents an innovative and progressive alternative to the conventional fed-batch processes, particularly in the production of complex biologics. It entails seamless and uninterrupted processing from initial cell culture to the final drug substance. This patented technique optimizes quality, efficiency, and flexibility in delivery.
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.